Clinical Trial Update: Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessing safety and feasibility of combining irradiation with nivolumab in esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Oslo University Hospital | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING